Related Experiment Video
Updated: Aug 8, 2026

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Early-Life Antibiotic Exposure Disrupts Bifidobacterium in Infants: A qPCR-Based Cohort Study
Dina Mohammed Abdel-Hady1, Mayada Sabry Zeid1, Eman Hamdy Mohamed2
1From the Pediatric Department-Faculty of Medicine.
Insights
Early antibiotic exposure significantly reduces Bifidobacterium levels in infants, disrupting gut microbiome development. This highlights the need for careful antibiotic use and strategies to restore microbial balance in early life.
Area of Science:
- Microbiome research
- Pediatric health
- Antibiotic stewardship
Background:
- Early infancy is crucial for gut microbiome development, with Bifidobacterium species playing key roles.
- Antibiotic exposure during this period may negatively impact microbial development.
- Limited quantitative data exist on the long-term effects of early-life antibiotics on the gut microbiome.
Purpose of the Study:
- To evaluate the impact of systemic antibiotic exposure within the first six months of life on Bifidobacterium abundance.
- To utilize quantitative real-time polymerase chain reaction (qPCR) for precise measurement in a prospective infant cohort.
Main Methods:
- Seventy healthy term infants were prospectively followed from birth to six months.
- Stool samples were analyzed using qPCR to quantify Bifidobacterium genus levels.
- Infants were grouped into antibiotic-exposed (n=27) and non-exposed (n=43) cohorts for comparison.
Main Results:
- Antibiotic-exposed infants showed significantly lower Bifidobacterium levels at 1, 3, and 6 months compared to non-exposed infants (P < 0.001).
- Non-exposed infants exhibited a typical increase in Bifidobacterium from 1 to 3 months, while exposed infants showed a decline from 1 to 6 months (P = 0.009).
- Clinical factors like delivery mode or feeding type did not predict Bifidobacterium levels in exposed infants.
Conclusions:
- Antibiotic exposure in early infancy causes persistent suppression of Bifidobacterium, hindering normal gut microbiome maturation.
- These findings emphasize the importance of judicious antibiotic use in infants.
- Strategies to restore gut microbial balance post-antibiotic therapy are needed.
Background:
Early infancy represents a critical window for establishing the gut microbiome, during which Bifidobacterium species dominate and play essential roles in metabolic, immune and intestinal maturation. Antibiotic exposure during this sensitive period may disrupt microbial development, yet quantitative data on its longitudinal impact remain limited. To evaluate the effect of systemic antibiotic exposure during the first 6 months of life on the abundance of Bifidobacterium using quantitative real-time polymerase chain reaction in a prospective infant cohort.
Methods:
Seventy healthy term infants were enrolled at birth and followed at 1, 3 and 6 months. Stool samples were analyzed using quantitative real-time polymerase chain reaction targeting genus-level Bifidobacterium. Infants were categorized into antibiotic-exposed (n = 27) and nonexposed (n = 43). Demographic and clinical variables were compared, and longitudinal and multivariate analyses were used to assess factors associated with Bifidobacterium abundance.
Results:
No significant baseline differences were observed between groups. Antibiotic-exposed infants demonstrated significantly lower Bifidobacterium levels at all measured time points (P < 0.001). Nonexposed infants showed the expected rise in Bifidobacterium from 1 to 3 months, whereas exposed infants exhibited a significant decline from 1 to 6 months (P = 0.009). Multivariate regression analysis indicated that clinical factors, such as delivery mode, feeding type, gestational age and maternal intrapartum antibiotics, were not significant predictors of Bifidobacterium levels among exposed infants.
Conclusions:
Antibiotic exposure in the first 6 months leads to persistent suppression of Bifidobacterium, disrupting normal microbiome maturation. These findings underscore the importance of cautious antibiotic use in early infancy and highlight the need for strategies to restore microbial balance following antibiotic therapy.
Related Concept Videos
Microbiota Modulation by Antibiotics
Development of the Oral Microbiota
Development of Human Microbiota
Gene Regulation in Microbial Communities: Quorum Sensing
Antibiotic Selection
Dysbiosis of the Gut Microbiota
